Suppr超能文献

生活方式医学作为难治性高血压的治疗方法。

Lifestyle Medicine as a Treatment for Resistant Hypertension.

机构信息

Institute of Biomedicine (iBiMED), School of Health Sciences, University of Aveiro, Aveiro, Portugal.

University of Maia, Research Center in Sports Sciences, Health Sciences and Human Development, Castêlo da Maia, Portugal.

出版信息

Curr Hypertens Rep. 2023 Oct;25(10):313-328. doi: 10.1007/s11906-023-01253-5. Epub 2023 Jul 20.

Abstract

PURPOSE OF REVIEW

Approximately 10% of the adults with hypertension fail to achieve the recommended blood pressure treatment targets on 3 antihypertensive medications or require ≥ 4 medications to achieve goal. These patients with 'resistant hypertension' have an increased risk of target organ damage, adverse clinical events, and all-cause mortality. Although lifestyle modification is widely recommended as a first-line approach for the management of high blood pressure, the effects of lifestyle modifications in patients with resistant hypertension has not been widely studied. This review aims to provide an overview of the emerging evidence on the benefits of lifestyle modifications in patients with resistant hypertension, reviews potential mechanisms by which lifestyles may reduce blood pressure, and discusses the clinical implications of the recent findings in this field.

RECENT FINDINGS

Evidence from single-component randomized clinical trials demonstrated that aerobic exercise, weight loss and dietary modification can reduce clinic and ambulatory blood pressure in patients with resistant hypertension. Moreover, evidence from multi-component trials involving exercise and dietary modification and weight management can facilitate lifestyle change, reduce clinic and ambulatory blood pressure, and improve biomarkers of cardiovascular risk. This new evidence supports the efficacy of lifestyle modifications added to optimized medical therapy in reducing blood pressure and improving cardiovascular risk biomarkers in patients with resistant hypertension. These findings need to be confirmed in larger studies, and the persistence of benefit over extended follow-up needs further study.

摘要

目的综述

约 10%的高血压成人患者服用 3 种降压药物未能达到推荐的血压治疗目标,或需要 ⁇ 4 种药物才能达到目标。这些“难治性高血压”患者靶器官损害、不良临床事件和全因死亡率的风险增加。虽然生活方式改变被广泛推荐作为高血压管理的一线方法,但生活方式改变对难治性高血压患者的影响尚未得到广泛研究。本综述旨在概述难治性高血压患者生活方式改变的益处方面的新证据,回顾生活方式可能降低血压的潜在机制,并讨论该领域最近发现的临床意义。

最近的发现

来自单一成分随机临床试验的证据表明,有氧运动、减肥和饮食改变可以降低难治性高血压患者的诊室血压和动态血压。此外,涉及运动、饮食改变和体重管理的多成分试验的证据可以促进生活方式的改变,降低诊室血压和动态血压,并改善心血管风险的生物标志物。这一新证据支持在优化药物治疗的基础上增加生活方式改变可降低难治性高血压患者的血压并改善心血管风险生物标志物。这些发现需要在更大的研究中得到证实,并且需要进一步研究延长随访期间的获益持续性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验